GlassScriptPhysician profile
Kevin S Caperton
NPI 1417096348
$20,878.78
in general payments reported to CMS, 2019-2025
9 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,360 · 2020: $2,574 · 2021: $309 · 2022: $2,425 · 2023: $3,813 · 2024: $5,191 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,250 · Food and Beverage: $1,164 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,250.00 |
| Food and Beverage | $1,163.60 |
| Travel and Lodging | $797.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $15,695.28 | 2019-2024 | Djo Surgical |
| Pylant Medical | $3,304.52 | 2019-2024 | |
| Stryker Corporation | $1,725.20 | 2019-2025 | Alphavent, Salvation, Flexible Guide Pin (Stryker Acl Versitomic) |
| Smith+Nephew, INC. | $66.42 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $23.03 | 2021 | |
| Abbott Laboratories | $21.33 | 2019 | |
| Core Surgical Group | $18.00 | 2025 | |
| Vericel Corporation | $13.77 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Caperton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.